Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in Florida who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year
Abstract Chronic diseases, such as obesity and diabetes, cardiovascular, and inflammatory bowel diseases (IBD) share common features in their pathology
Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist, working by imitating the activity of the GLP-1 hormone
Through this, we can help pinpoint what might be triggering your hormonal acne and provide targeted recommendations
What does the clinical evidence actually say about semaglutide and lactation
Nauck MA, Kahle M, Baranov O, Deacon CF, Holst JJ